SecBot SecBot
8-K ·Filed Apr 8, 2026

DMAAR

Drugs Made In America Acquisition Corp.
BULLISH
Impact 7/10
Horizonweeks Processed6mo ago SEC0001213900-26-041284
8-K context-dependent: Items 8.01
Actionable Insight ▲ Bullish

Monitor for definitive business combination agreement and Form S-4 filing, which will provide final terms, including share exchange ratios and PIPE financing details. The $25M-$50M minimum cash condition suggests potential redemptions will be a key factor in deal completion.

DirectionBullish
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

Executive Summary

Drugs Made In America Acquisition Corp. (DMAAR) entered into a non-binding letter of intent to acquire Power Analytics Global Corp. in a de-SPAC transaction valued at approximately $1.0 billion. The deal is subject to due diligence and definitive agreement.

Key Facts

  • DMAAR entered into a non-binding LOI with Power Analytics Global Corp. (PAGC) for a de-SPAC transaction
  • Target valuation is approximately $1.0 billion, subject to adjustments
  • Transaction includes minimum cash condition of $25M to $50M
  • LOI is non-binding except for trust account and confidentiality provisions
  • Definitive agreement and Form S-4 filing expected

Financial Impact

Approximately $1.0 billion implied equity valuation for Power Analytics Global Corp.

valuationcash positiondilution

Risk Factors

  • Deal is non-binding and subject to due diligence
  • Minimum cash condition may not be met if redemptions are high
  • No guarantee definitive agreement will be executed

Market Snapshot

Exchange
Nasdaq
Sector
Blank Checks

Investment Themes

Traditional Finance

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-041284
Document: ea028552701ex10-1.htm0001213900-26-041284
Document: 0001213900-26-041284-index-headers.html0001213900-26-041284
Document: 0001213900-26-041284-index.html0001213900-26-041284
Document: 0001213900-26-041284.txt0001213900-26-041284
3 reports for DMAAR
Performance horizon
Filters
Rows
Reports for DMAAR — sortable, filterable
TypeNow
May 5, 2026
25w ago
8-K
NEUTRAL ★ 6/10
—awaiting T+20——
May 1, 2026
25w ago
8-K
BEARISH ★ 7/10
—awaiting T+20——
Apr 8, 2026
28w ago
8-K
BULLISH ★ 7/10
—awaiting T+20——
Showing 3 of 3

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 8, 2026